---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-256062"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:11:28.618429+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve extension of Bellevue Life Sciences SPAC deadline to Feb 2025; 44% of shares redeemed

## Summary
- Charter amended to extend business combination deadline from Nov 14, 2024 to Feb 14, 2025.
- Charter amended to remove net tangible asset requirement to avoid penny stock rules.
- 1,766,469 shares (approx. 44% of outstanding) tendered for redemption.
- Five existing directors re-elected at annual meeting.
- Quorum was 71.24% of outstanding shares; proposals approved overwhelmingly.

## SEC filing metadata
- accession: 0001193125-24-256062
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524256062/0001193125-24-256062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524256062/d812587d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-256062
- JSON: https://secwatch.observer/filing/0001193125-24-256062.json
- Plain text: https://secwatch.observer/filing/0001193125-24-256062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.